New Research-Based Report in Biodex Software Promotes Safer Return-to-Play After ACL Reconstruction
Summary
The first-ever Return-to-Play report displays isokinetic test results with clear pass/fail to aid in communication with physicians and athletes throughout the athlete’s recovery. Backed by current research and supported by a panel of experts, the report is designed to give patients and referring physicians the added confidence they are ready to return to play. “The high failure of ACL reconstruction and the debate of when to return to play is a very active conversation throughout the world,” states Ed Behan, Sr. Vice President, Market Development at Biodex. “The new report is a first, and we’re grateful to have had so many key opinion leaders participating in its creation.” Live chat with Biodex representatives during the NATA Athletic Trainers’ Virtual Convention, July 13-15, or visit https://www.biodex.com/s4bx for more information. With a history of manufacturing and engineering excellence that spans more than 60 years, the Biodex mission is to provide innovative solutions and customer-driven support to medical facilities and wellness centers around the globe.